Backing a platform for heme-protein production.
Synfera is an early-stage biotechnology company in Calgary, Alberta, advancing Aerus while building capabilities for a broader portfolio of heme proteins and partner programmes.
Founded by an award-winning international competition team
Teams competed; Synfera's project earned a gold medal
In preparation, with pilot partners being onboarded
Targeted price advantage over market alternatives
Why Synfera, and why now.
A production platform, not a single product
Synfera is building around the production of complex heme proteins. Aerus is the flagship programme and prospective partner projects broaden the path forward.
Cost structure as a moat
At the working concentration for cell culture, our target price sits more than 25% below current alternatives without trading away effectiveness.
Recognised technical origin
Synfera was founded out of a team whose project won a gold medal, the Best Safety and Security Award, and a Best Entrepreneurship nomination.
Stage of development.
Engineered oxygen carrier based on a natural macromolecule
In-house data generation on proliferation and productivity
Product form and storage specification for cell culture
Early partners piloting in cell culture applications
Recent recognition
Synfera featured in the Connect2Innovate team showcase
Read on Connect2Innovate →First Runner-up at the 2025 iGEM Startup Showcase
Read on iGEM Innovation (LinkedIn) →Can earthworms bring relief to a global blood donor shortage?
Read on University of Calgary News →Investor and partnership inquiries.
Reach the Synfera team directly at business@synfera.ca to request materials or arrange a conversation.